At a glance
- Originator Nissan Chemical Industries
- Class Antiarrhythmics; Benzopyrans; Small molecules
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 13 Feb 2006 Discontinued - Preclinical for Arrhythmias in Japan (unspecified route)
- 23 Aug 2004 Data presented at the 18th World Congress of International Society for Heart Research (ISHR-2004) has been added to the Arrhythmias pharmacodynamics section
- 02 Apr 2002 A preclinical study has been added to the Arrythmias pharmacodynamics section